Blog

Our Experts Comment the Times Series

See All the Comments
rss

One’s Pain Is Another’s Gain

28 March 2019 by jbchevrel

Suedzucker (SZUGR) 5y CDS has widened c30bp since the Mar 20th roll. It announced a profit warning ahead of its FY results in May. SZUGR expects revenues €6.75b EBITDA €350m (lower end of the forecast range). That decrease is largely due to the sugar segment. SZUGR plans to write down €700m goodwill, facing restructuring charges of €150m (€100m due to write downs on fixed assets). The good news for credit (vs equity, all is relative) may be the dividend cut (€0.20 ps from €0.45), This saves €50m. SZUGR also announced it is likely to trigger the cashflow trigger (cashflow/revenue <5%) on its hybrid bond (ie they will not pay its coupon on for 1y = 4 quarters, until the covenant is tested again in 2020). This saves €20m. Looking forward, SZUGR expects for 19/20 revenues €6.7bn EBITDA €100m (with a loss of €200m-€300m in sugar). If net leverage effectively rises closer to 6x, it is likely to result in S&P revising its outlook to Negative from BBB- s. That would arguably not be a game changer, as Moody’s rating is already Baa3n, which is why SZUGR has gone from iTraxx Main to Xover. Its CDS remains quite consistent with cash, with Z-spread of 160 on the 2023s and 190 on the 2025s.